Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 23, 2017Neuromuscular DisordersOpen Access

Diagnosis and management of spinal muscular atrophy: Part 2: Pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics

View Full Paper
Ask AI
Bookmark
Share

Authors

RFRichard S. FinkelHeart Failure / CardiomyopathyEugenio MercuriEugenio MercuriUniversity of SienaOMOscar H. MeyerBoston Children's Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Finkel et al. (2017) studied this question.

synapsesocial.com/papers/69dcc337d4d0de07d1133a13https://doi.org/10.1016/j.nmd.2017.11.004
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Mitochondrial dysfunction in a neural cell model of spinal muscular atrophy2009 · 99 citations
  2. 2Spinal Muscular Atrophy: Survival Pattern and Functional Status2004 · 179 citations
  3. 3Pilot trial of albuterol in spinal muscular atrophy2002 · 127 citations
  4. 4Spinal Muscular Atrophy Type 12011 · 18 citations
  5. 5Spinal muscular atrophy: a motor neuron disorder or a multi‐organ disease?2013 · 275 citations